Your browser is no longer supported. Please, upgrade your browser.
ITRM [NASD]
Iterum Therapeutics plc
Index- P/E- EPS (ttm)-1.62 Insider Own0.20% Shs Outstand180.02M Perf Week0.60%
Market Cap96.69M Forward P/E- EPS next Y-0.23 Insider Trans0.00% Shs Float176.16M Perf Month-14.32%
Income-114.50M PEG- EPS next Q0.12 Inst Own11.20% Short Float0.78% Perf Quarter-52.14%
Sales- P/S- EPS this Y69.50% Inst Trans0.02% Short Ratio0.21 Perf Half Y-49.91%
Book/sh0.26 P/B2.06 EPS next Y17.90% ROA-163.40% Target Price- Perf Year-40.11%
Cash/sh0.52 P/C1.03 EPS next 5Y- ROE- 52W Range0.45 - 2.99 Perf YTD-45.80%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-82.10% Beta1.26
Dividend %- Quick Ratio2.80 Sales past 5Y- Gross Margin- 52W Low18.85% ATR0.04
Employees7 Current Ratio2.80 Sales Q/Q- Oper. Margin- RSI (14)40.42 Volatility4.99% 7.14%
OptionableNo Debt/Eq0.54 EPS Q/Q104.80% Profit Margin- Rel Volume0.43 Prev Close0.55
ShortableYes LT Debt/Eq0.44 EarningsAug 13 BMO Payout- Avg Volume6.53M Price0.54
Recom3.00 SMA20-3.20% SMA50-14.07% SMA200-56.67% Volume2,808,162 Change-2.65%
May-28-21Upgrade Gabelli & Co Sell → Hold
Mar-15-21Upgrade H.C. Wainwright Neutral → Buy $2.50
Jun-02-20Downgrade RBC Capital Mkts Outperform → Sector Perform $7 → $2
Jan-21-20Downgrade Gabelli & Co Buy → Sell
Dec-11-19Downgrade SVB Leerink Outperform → Mkt Perform
Jun-21-19Initiated H.C. Wainwright Buy $17
Oct-04-21 02:58PM  
01:28PM  
12:33PM  
11:05AM  
10:45AM  
10:00AM  
09:40AM  
08:36AM  
07:30AM  
05:34AM  
Oct-03-21 07:55PM  
10:20AM  
10:00AM  
Oct-01-21 07:00PM  
03:45PM  
03:09PM  
11:30AM  
11:00AM  
09:13AM  
07:45AM  
07:00AM  
05:22AM  
Sep-30-21 11:05PM  
11:45AM  
11:00AM  
09:00AM  
08:10AM  
08:00AM  
05:21AM  
Sep-29-21 08:40PM  
08:05PM  
01:00PM  
12:20PM  
09:20AM  
08:30AM  
07:03AM  
Sep-28-21 06:29PM  
04:50PM  
04:05PM  
03:50PM  
02:00PM  
01:15PM  
08:55AM  
08:00AM  
07:50AM  
07:30AM  
05:40AM  
Sep-27-21 09:10PM  
08:45PM  
01:46PM  
12:15PM  
10:30AM  
09:40AM  
09:20AM  
08:30AM  
05:40AM  
Sep-26-21 12:00PM  
10:40AM  
10:37AM  
Sep-25-21 09:05AM  
Sep-24-21 01:15PM  
12:15PM  
10:30AM  
10:00AM  
Sep-23-21 08:53PM  
07:23PM  
06:13PM  
04:48PM  
11:35AM  
11:00AM  
05:40AM  
Sep-22-21 09:07PM  
04:40PM  
Sep-21-21 07:15PM  
06:45PM  
02:25PM  
02:00PM  
12:45PM  
12:10PM  
Sep-19-21 10:21AM  
Sep-17-21 07:30PM  
11:30AM  
11:00AM  
06:00AM  
Sep-16-21 03:10PM  
Sep-15-21 09:17PM  
08:49PM  
08:15PM  
Sep-14-21 10:00AM  
09:18AM  
Sep-13-21 06:00PM  
05:08PM  
12:40PM  
12:02PM  
10:45AM  
10:00AM  
Sep-10-21 05:45PM  
04:40PM  
11:35AM  
11:00AM  
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was founded in 2015 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DENNER ALEXANDER J10% OwnerFeb 12Sale2.2710,619,94924,107,2840Feb 12 08:22 PM
DENNER ALEXANDER J10% OwnerFeb 11Sale2.5910,000,00025,900,00010,619,949Feb 12 08:22 PM
Fishman Corey N.President & CEOJan 26Sale1.7385,445147,820322,008Jan 27 07:35 PM
Dunne Michael W.DirectorJan 26Sale1.7333,14357,337256,355Jan 27 07:32 PM
Matthews Judith M.Chief Financial OfficerJan 26Sale1.7333,86858,59228,632Jan 27 07:32 PM